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Seroprevalence Of HBV,HCV and HIV Viruses among Blood
Donors in Al- Mukalla – Hadhramout- Yemen
Ahmed Mubarak daakeek*
Abstract
This Retrospective study was done during the year 2009 to determine the seroprevalence of hepatitis B virus (HBV),
hepatitis C virus (HCV) and human immunodeficiency virus (HIV), among blood donors in Al-Mukalla hospitals
blood banks – Hadhramout-Yemen. Data was collected from blood banks, recorded and grouped according to their
serology results. A total of 4526 blood donors were registered during the study period. 252 of them (5.3%) were
hepatitis B surface antigen (HBsAg) positive, 29 (0.6%) were anti-hepatitis C virus (anti- HCV) positive and 4
(0.09%) were- anti- human immunodeficiency virus(Anti- HIV) positive. Their average age was between 18 -50
years, and all positive cases were males. The seroprevalence rate of positive hepatitis B surface antigen (HBsAg)
among blood donors was intermediate in relations to other areas in our country but higher than worldwide except
African countries. Anti-HCV among this sample was lower than other areas in our country and similar in being low if
compared to international findings. Anti-HIV was low and similar to regional and Asian countries.
Keywords: HBV; HCV; HIV; Blood donors; Al-Mukalla; Yemen.

Introduction:
The discovery of transfusion-transmissible
infections (TTIs) has heralded a new era in blood
transfusion practice worldwide with emphasis on
two fundamental objectives, safety and
protection of human life. Hepatitis C virus
(HCV), human immunodeficiency virus(HIV)
and hepatitis B virus (HBV) are the three most
important agents responsible for transfusion
transmitted infections (TTIs) [28]. The risk of
transmitting hepatitis through transfusions of
blood and blood products has been known since
1950 (28). In 1965, Blumberg reported the
discovery of the hepatitis B surface antigen
(HBsAg) [28]. Hepatitis B virus (HBV) is the
most common cause of serious liver infection in
the world and is said to have infected more than
two billion people [26].
The World Health Organization (WHO) reported
that approximately 350 million people are
chronically infected with the hepatitis B virus
and 170 million people carry the hepatitis C virus
worldwide [20]. The hepatitis C virus was
discovered in 1989 as the major causative agent
of non A and non B hepatitis (3). The hepatitis C
virus is transmitted via blood and blood products,
both parenterally and through sexual contact [3].
The first case of transfusion-associated AIDS
was described in an infant given transfusion for
erythroblastosis foetalis [21]. Thereafter, many
cases were reported all over the world in which
transfusion of blood and its products was the
only
risk
factor
[33,41].
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immunodeficiency syndrome (AIDS) is the
leading universal health problem of considerable
socioeconomic impact. In 2005, the United
Nations Program reported that 40.3 million
people are living with AIDS, of which 7.4
million in East and Southeast Asia [42].
However, some countries reported low levels of
HIV epidemic such as in Afghanistan, Egypt,
Iraq, Jordan, Lebanon, Libya, Morocco,
Palestine, Qatar, Saudi Arabia, Syria, Tunisia,
United Arab Emirates and Yemen (44).
However, limited biological supervision of HIV
infection may not reflect the true prevalence
among the populations in these countries [44].
With every unit of blood, there is 1% chance of
transfusion-associated
problems
including
transfusion-transmitted diseases [9]. Among all
infections, HIV and hepatitis are the most
dreadful (9). The improved screening and testing
of blood donors has significantly reduced
transfusion-transmitted
diseases
in
most
developed countries (9). Poor health education
and lack of awareness result in the reservoir of
infections in the population.
The present study has been conducted to screen
the HIV, HBV and HCV in blood donors at the
blood bank units of Ibn-Sina and Al- Mukalla
hospitals in Al- Mukalla city- capital of
Hadhramout governorate.
Materials and methods:
This descriptive retrospective study was done
among blood donors that attend blood banks in
Ibn-Sina general hospital and Al-Mukalla
hospital for childhood and maternity in AlMukalla city –Hadhramout at a period of January
to December 2009. These hospitals are the two
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only governmental
tertiary level teaching
hospitals that provides health services to people
in Mukalla city and all Hadhramout and nearby
governorates.
Blood donors were either volunteers, or relatives
or friends of recipient patients. All of them were
Yemeni nationality. Data was collected from
blood banks records, and donors were grouped
according to serology results.
Inclusion Criteria: Apparently healthy donors of
age 18 to 50 years with body weight above 45 kg
would qualify for donation.
Exclusion Criteria: Individuals with anemia or
past history of jaundice as well as those with a
last blood donation not exceeding 4 months were
excluded. Female donors don't accepted if
pregnant or nursing or had a menstrual cycle.
In the blood banks, the first step in screening for
potential blood donors was taking age and past
medical history of the client. Individuals were
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required to give answers to questions on previous
illnesses and medical conditions, and past history
of blood transfusion, but there is no written
logbook. For that, there were no information
about age, residency, occupation and blood
grouping of donors.
ELISA tests were used for investigation of
HbsAg, anti-HBc and anti-HIV antibodies.
Data were analyzed by Microsoft Office Excel
2010.
Results:
During the period of year 2009, 4526 individuals
visited Ibn-Sina and Al-Mukalla hospitals for
donation of blood. The age of donors range from
18 to 50 years old and almost all of them were
volunteers, relatives or friends of recipient
patients. The Majority of donors were males
(4523, 99.93%) and only 3 donors (0.07%) were
females (Table 1).

Table (1) Distribution of blood donors according to sex
Gender
Male
Female
Total

Frequency
4523
3
4526

After going through the process of screening, it
was found that 252 (5.6%) were suffering from
HBV infection and all of them were males. A

Percent
99.93
0.07
100

total of 29 (0.6%) donors were infected with
HCV and 4 of them (0.09%) were positive for
HIV all of them were males. (Table 2).

Table(2): Prevalence of positive antibodies against HBV, HCV and HIV in all Blood donors study

Results

HBV (n&%)

HCV(n&%)

HIV(n&%)

Positive

252(5.6)

29(0.6)

4 (0.09)

Negative

4274(94.4)

4497(99.4)

4522(99.91)

Total

4526(100)

4526(100)

4526(100)

The seroprevalence of HBV, HCV and HIV is
purely among male blood donors included in this
study, and no positive cases for HbsAg, anti-HBc
and anti-HIV were detected in the 3 cases of
female donors.
Discussion:
In this study an attempt had been made to define
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the seroprevalence of Hepatitis B, C and HIV
among healthy donor population mostly from
Hadhramout and nearby governorates. Data
consists of analysis of one year (January to
December 2009).
In this study, 4526 individuals were investigated
for HBV, HCV and HIV; Most of them were
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males. This is due to low hemoglobin level in
females in our community and the fact that
women are less willing to donate blood due to
cultural aspects in the community. The high
ratio of male to female blood donors in Yemen
was similar to other countries [8,16,23]. The 3
female donors in this study were donated blood
due to a rare blood grouping (2 cases) or an
emergency requirement of blood in absence of
male donors (1 cases).

HBV
HCV
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The study showed that the seroprevalence of
HBV among blood donors in Al-Mukalla city
hospitals was as high as 5.3%. This result had
similar rate or less than other studies conducted
in different cities in our country such as in Aden
(5.1%) [7], Taiz (7%) [31], Hajja (9.8%) [19]
(Fig. 1) and another study done by collecting
data from different governorates (10.8%) [12],
whereas lower rates were found in other studies
done in Al-Hodeida (2.35%) [34] and Sana
(1.72%, 2.1%) [4,39].

10%
8%
6%
4%
2%
0%

Fig.1: Prevalence of HBV and HCV in different cities in our country.
In the other hand, the seroprevalence of HBV
was higher compared to many other countries. In
regional and Arab countries, the rate in multiple
studies done in different places in Saudi Arabia
were (1.5%, 1.82% and 2.34%) [6,13,16,34], in
Emirates was (0.23%) [5], Qatar (0.9%) [17],
Iraq (4%) [8] and in Egypt (1.4%, 2.1%) [38,43].
In Asian countries HBV prevalence was also
lower than our study as in Iran (0.56% - 3.74%)
[10,22], India (1.7%, 2.23%) [11,32], but lower
or similar to our study in Pakistan
(2.28%,3.3%,5.96%) [23,24,25], and in Thailand
(4.61%) [27].
In African countries seroprevalence was variable,
higher as in Nigeria (7.50%) [37], and similar to
this study as in Ethiopia (4.7%) [40]. In Turkey,
the prevalence was lower than our study at some
studies (1.38%,1.76%) [1,2] but higher in other
study (4.19%) [18]. In other western and
developed countries, the prevalence is much
lower as in Germany (1.6%) [30], Canada
(0.124%) [14], and America (0.0756 %)
[15],Table (3).
The seroprevalence rates of hepatitis B were high
in Al-Mukalla. It was intermediate to other cities
in our countries and high in relation to other
countries except African countries. Transmission

of hepatitis B through unscreened blood
transfusion, and reuse of unsterilized syringes
and medical equipment are well documented in
the pertinent literature. Moreover, people having
cupping,
history
of
dental
treatment,
circumcision and shaving by barbers are also at
increased risk due to reuse of equipment.
We found that 0.6% of the blood donors were
positive for anti - HCV. This rate was the lower
rate in the Republic of Yemen. A higher rate was
seen in other studies among blood donors in our
country which reported that Anti-HCV were
about (0.79%) of the blood donors in Al-Hodeida
[35], (1%) in Taiz [31], (1.1%) in Hajja [19],
(1.3%) in Aden [7], (3%) in Sana [4] (Fig1), and
(2.7%) in other meta-analysis study performed in
different governorates in Yemen during the
period 2000-2005 [12]. Comparing to regional
and Arab countries; the rates were somewhat
similar to different studies in Saudi Arabia (0.4%
-0.59% %) [13,16,34], but lower rate in Emirates
(0.11%) [5], and higher rates in Qatar (1.39%)
[17], Iraq (1%) [8] and Egypt (3.5% -7.1% )
[38,43].
In Asian countries the seroprevalence was also
variable comparing to our study from lower
prevalence in Iran (0.12%) [10], similar to higher
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prevalence in India (0.66%-1.0%) [11,32], low to
higher prevalence in Pakistan (0.07% -4.0%)
[23,24,25], to higher prevalence in Thailand
(2.90%) [27]. In African countries e.g. Ethiopia
and Nigeria, the prevalence was somewhat
similar to slight higher than our study (0.7%)

Ahmed Mubarak daakeek

(0.96%) [37,40]. In contrast, the prevalence in
developed countries was lower than our study
like Turkey (0.07%- 0.38%) [1,2,18], Germany
(0.00002%) [30], Canada (0.1683%) [14], and
America (0.299%) [15] Table (3).

Table (3): Prevalence of HBV and HCV in different countries comparing to our study
HCV prevalence %

HBV prevalence %

Country

0.60

5.30

Al-Mukalla-Yemen

0.4- 0.59

1.5-2.34

Saudi Arabia

0.11

0.23

Emirates

1.39

0.90

Qatar

1

4.00

Iraq

3.5-7.1

1.4-2.1

Egypt

0.12

0.56 - 3.74

Iran

0.66-1

1.7-2.23

India

0.07- 4

2.23-5.96

Pakistan

2.90

4.61

Thailand

0.70

7.50

Nigeria

0.96

4.70

Ethiopia

0.7-038

1.38- 4.19

Turkey

The seroprevalence of anti-HCV in Al-Mukalla
was low in comparing with other cities in the
Republic and most other countries despite the
same transmission route as HBV which shows
high prevalence and there is no clear explanation
for that.
HIV infection rate among blood donors in this
study was low (0.09%), in comparison with other
studies in Al-Hodeida-Yemen (0.14) [35] , SanaYemen (0.39%) [36], Makah in Saudi Arabia
(0.12%)[34], India (0.3%, 0.56%) [11,32],
Thailand (0.69%) [27], Ethiopia (3.8%) [40],
Kenya (2-20%) [29] and Nigeria (0.96%) [37],
but higher than that reported in Emirates
(0.004%) [5], Iran (0.004%) [10], Pakistan
(0.007%, 0.02%) [13,23], Turkey (0.008%) [1],
Canada (0.00038%) [14], America (0.0097%)
[15] and Germany (0.000018%) [30].
The seroprevalence of HIV among blood donors
in Al-Mukalla is low and it is going with low
prevalence in the region despite high contact of
Yemeni people with people from African
countries where HIV transmission risk is high.
There are however some shortcomings in our
study, one of these is the absence of
classifications of donors to age groups, and the
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other is lack of blood grouping of donors, and
this is due to the absence of related information
from the blood banks.
Conclusion:
Among blood donors that were screened, the
seroprevalence of hepatitis B was much higher in
Al-Mukalla and in our country, where HCV has
a similar - low prevalence comparing to most of
countries worldwide. HIV has low prevalence of
all blood borne viruses among blood donors.
Given the lack of information on the prevalence
of hepatitis B, C and HIV in the general
population in Yemen, we recommend a
population based study for the assessment of
hepatitis B, C and HIV prevalence as a first step
to implement control measures.
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مجمة جامعة حضرموت لمعموم الطبيعية والتطبيقية المجمد ,41العدد  ,2ديسمبر 2144م

مدى االنتشار املصلي لعدوى التهاب الكبد "بي" و "سي" وفريوس نقص املناعة
البشري بني املتربعني بالدم يف مدينه املكال – اليمن
أحمد مبارك دعكيك
الممخص
أجريت الدراسة خالل العام  2116لبيان مدى فيروسات الكبد الوبائي "بي" و" سي" وفيروس نقص المناعة المكتسبة بين المتبرعين بالدم في
مدينة المكال -حضرموت .تم جمع المعمومات من سجالت بنوك الدم  ,وتم تقسيم المتبرعين حسب نتائج فحوصاتهم المصمية ,وشممت
الدراسة  1223متبرعاً بالدم الذين حضروا إلى بنوك الدم بمستشفيات مدينة المكال .وكانت منهم  222حالة ( )%2.5إيجابية لفيروس الكبد
"بي" و 26حالة ( )%1.3لفيروس الكبد "سي" و 1حاالت( )%1.16لفيروس نقص المناعة البشري .كان أعمار الحاالت بين  21-45سنة

ذكور .كان معدل إيجابية فيروس الكبد "بي " في المتبرعين بالدم متوسطا مقابمة مع مناطق أخرى في اليمن
وكل الحاالت اإليجابية كانت
اً
ولكنها كانت عالية بالنسبة لدول المنطقة ودول العالم باستثناء الدول األفريقية .أما فيروس الكبد " سي" فكان منخفضا بالمقابمة مع المناطق

األخرى في بالدنا و منخفض إ لى مماثل لبقية البمدان .فيروس نقص المناعة المكتسب كان منخفضا أو مماثال لبقية بمدان المنطقة والبمدان
األسيوية.
الكممات المفتاحية :فيروس الكبد "بي" ,فيروس الكبد "سي"  ,فيروس نقص المناعة البشري ,المتبرعون بالدم ,المكال.
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